The 31st Annual International AF Symposium is an intensive three-day medical conference held February 5-7, 2026, at the Omni Boston Hotel at the Seaport in Boston, Massachusetts. It brings together leading scientists and clinicians to discuss advances in atrial fibrillation research, diagnosis, management, and treatment.
Sessions cover topics such as prediction and risk factors for AF, new electrophysiology technologies, case transmissions, stroke risk management, biophysics of pulsed field ablation, ablation endpoints and outcomes, and challenging cases. The event includes late-breaking clinical trials, real-time case presentations, and networking opportunities.
Initiated in 1995 amid the rising prevalence of atrial fibrillation, the symposium provides updates on basic, translational, and clinical science from prominent investigators.
